Clinical evidence of inflammation driving secondary brain injury: a systematic review - PubMed (original) (raw)
Review
Clinical evidence of inflammation driving secondary brain injury: a systematic review
Holly E Hinson et al. J Trauma Acute Care Surg. 2015 Jan.
Abstract
Background: Despite advances in both prevention and treatment, traumatic brain injury (TBI) remains one of the most burdensome diseases; 2% of the US population currently lives with disabilities resulting from TBI. Recent advances in the understanding of inflammation and its impact on the pathophysiology of trauma have increased the interest in inflammation as a possible mediator in TBI outcome.
Objectives: The goal of this systematic review is to address the question: "What is the evidence in humans that inflammation is linked to secondary brain injury?" As the experimental evidence has been well described elsewhere, this review will focus on the clinical evidence for inflammation as a mechanism of secondary brain injury.
Data sources: Medline database (1996-Week 1 June 2014), Pubmed and Google Scholar databases were queried for relevant studies.
Study eligibility criteria: Studies were eligible if participants were adults and/or children who sustained moderate or severe TBI in the acute phase of injury, published in English. Studies published in the last decade (since 2004) were preferentially included. Trials could be observational or interventional in nature.
Appraisal and synthesis methods: To address the quality of the studies retrieved, we applied the Grades of Recommendation, Assessment, Development, and Evaluation (GRADE) criteria to assess the limitations of the included studies.
Results: Trauma initiates local central nervous system as well as systemic immune activation. Numerous observational studies describe elevation of pro-inflammatory cytokines that are associated with important clinical variables including neurologic outcome and mortality. A small number of clinical trials have included immunomodulating strategies, but no intervention to date has proven effective in improving outcomes after TBI.
Limitations: Inclusion of studies not initially retrieved by the search terms may have biased our results. Additionally, some reports may have been inadvertently excluded due to use of non-search term key words. Conclusions and Implications of Key Findings Clinical evidence of inflammation causing secondary brain injury in humans is gaining momentum. While inflammation is certainly present, it is not clear from the literature at what juncture inflammation becomes maladaptive, promoting secondary injury rather than facilitating repairand identifying patients with maladaptive inflammation (neuro-inflammation, systemic, or both) after TBI remains elusive. Direct agonism/antagonism represents an exciting target for future study.
Level of evidence: Systematic review, level III.
Figures
Figure 1
Search algorithm and results.
Similar articles
- Beyond the black stump: rapid reviews of health research issues affecting regional, rural and remote Australia.
Osborne SR, Alston LV, Bolton KA, Whelan J, Reeve E, Wong Shee A, Browne J, Walker T, Versace VL, Allender S, Nichols M, Backholer K, Goodwin N, Lewis S, Dalton H, Prael G, Curtin M, Brooks R, Verdon S, Crockett J, Hodgins G, Walsh S, Lyle DM, Thompson SC, Browne LJ, Knight S, Pit SW, Jones M, Gillam MH, Leach MJ, Gonzalez-Chica DA, Muyambi K, Eshetie T, Tran K, May E, Lieschke G, Parker V, Smith A, Hayes C, Dunlop AJ, Rajappa H, White R, Oakley P, Holliday S. Osborne SR, et al. Med J Aust. 2020 Dec;213 Suppl 11:S3-S32.e1. doi: 10.5694/mja2.50881. Med J Aust. 2020. PMID: 33314144 - The Effectiveness of Integrated Care Pathways for Adults and Children in Health Care Settings: A Systematic Review.
Allen D, Gillen E, Rixson L. Allen D, et al. JBI Libr Syst Rev. 2009;7(3):80-129. doi: 10.11124/01938924-200907030-00001. JBI Libr Syst Rev. 2009. PMID: 27820426 - The impact of pre-injury anticoagulation therapy in the older adult patient experiencing a traumatic brain injury: A systematic review.
Smith K, Weeks S. Smith K, et al. JBI Libr Syst Rev. 2012;10(58):4610-4621. doi: 10.11124/jbisrir-2012-429. JBI Libr Syst Rev. 2012. PMID: 27820526 - Inflammation and neuroprotection in traumatic brain injury.
Corps KN, Roth TL, McGavern DB. Corps KN, et al. JAMA Neurol. 2015 Mar;72(3):355-62. doi: 10.1001/jamaneurol.2014.3558. JAMA Neurol. 2015. PMID: 25599342 Free PMC article. Review. - Elevation of the head during intensive care management in people with severe traumatic brain injury.
Alarcon JD, Rubiano AM, Okonkwo DO, Alarcón J, Martinez-Zapata MJ, Urrútia G, Bonfill Cosp X. Alarcon JD, et al. Cochrane Database Syst Rev. 2017 Dec 28;12(12):CD009986. doi: 10.1002/14651858.CD009986.pub2. Cochrane Database Syst Rev. 2017. PMID: 29283434 Free PMC article. Review.
Cited by
- Fluid biomarkers of chronic traumatic brain injury.
Friberg S, Lindblad C, Zeiler FA, Zetterberg H, Granberg T, Svenningsson P, Piehl F, Thelin EP. Friberg S, et al. Nat Rev Neurol. 2024 Oct 3. doi: 10.1038/s41582-024-01024-z. Online ahead of print. Nat Rev Neurol. 2024. PMID: 39363129 Review. - Plasma profiles of inflammatory cytokines in children with moderate to severe traumatic brain injury: a prospective cohort study.
Huang H, Fu G, Lu S, Chen S, Huo J, Ran Y, Xiao C, Chen J, Pi D, Zhou F, Dang H, Liu C, Fu YQ. Huang H, et al. Eur J Pediatr. 2024 Aug;183(8):3359-3368. doi: 10.1007/s00431-024-05604-5. Epub 2024 May 15. Eur J Pediatr. 2024. PMID: 38748253 - Chronic immunosuppression across 12 months and high ability of acute and subacute CNS-injury biomarker concentrations to identify individuals with complicated mTBI on acute CT and MRI.
Clarke GJB, Follestad T, Skandsen T, Zetterberg H, Vik A, Blennow K, Olsen A, Håberg AK. Clarke GJB, et al. J Neuroinflammation. 2024 Apr 27;21(1):109. doi: 10.1186/s12974-024-03094-8. J Neuroinflammation. 2024. PMID: 38678300 Free PMC article. - Post-Traumatic Cerebral Infarction: A Narrative Review of Pathophysiology, Diagnosis, and Treatment.
Poblete RA, Zhong C, Patel A, Kuo G, Sun PY, Xiao J, Fan Z, Sanossian N, Towfighi A, Lyden PD. Poblete RA, et al. Neurol Int. 2024 Jan 4;16(1):95-112. doi: 10.3390/neurolint16010006. Neurol Int. 2024. PMID: 38251054 Free PMC article. Review. - The neuroprotective potential of phytochemicals in traumatic brain injury: mechanistic insights and pharmacological implications.
Hasan GM, Anwar S, Shamsi A, Sohal SS, Hassan MI. Hasan GM, et al. Front Pharmacol. 2024 Jan 4;14:1330098. doi: 10.3389/fphar.2023.1330098. eCollection 2023. Front Pharmacol. 2024. PMID: 38239205 Free PMC article. Review.
References
- Langlois JA, Rutland-Brown W, Wald MM. The epidemiology and impact of traumatic brain injury: a brief overview. J Head Trauma Rehabil. 2006;21(5):375–378. - PubMed
- Lenzlinger PM, Morganti-Kossmann MC, Laurer HL, McIntosh TK. The duality of the inflammatory response to traumatic brain injury. Mol Neurobiol. 2001;24(1–3):169–181. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials